Shipping Address

Melagm-EK is a specialized dermatological formulation designed for the treatment of moderate-to-severe melasma and various hyperpigmentation disorders. By combining a potent corticosteroid, a retinoid, and a phenolic skin-lightening agent, it addresses the biological pathways of melanin production and skin cell turnover simultaneously.

Composition and Ingredients

Melagm-EK follows the "Kligman Formula" philosophy, utilizing a triple-combination approach to ensure maximum efficacy while managing irritation. Each gram typically contains:

Hydroquinone (2% - 4%): The gold standard for skin lightening. It inhibits the enzyme tyrosinase, which is essential for the conversion of DOPA to melanin.

Tretinoin (0.025% - 0.05%): A derivative of vitamin A (retinoic acid). It promotes keratinocyte turnover, effectively "shrouding" pigmented cells and allowing the hydroquinone to penetrate deeper into the skin layers.

Mometasone Furoate or Fluocinolone Acetonide: A medium-potency corticosteroid. Its primary role is to suppress the inflammatory response often triggered by tretinoin and hydroquinone, while also providing minor anti-melanogenic effects.

Therapeutic Indications

Melagm-EK is indicated for the short-term (up to 8 weeks) treatment of:

Melasma: Specifically the epidermal and mixed types are characterized by dark, symmetrical patches on the face.

Post-Inflammatory Hyperpigmentation (PIH): Dark spots remaining after acne, trauma, or dermatological procedures.

Senile Lentigines: Often referred to as "age spots" or "liver spots" caused by cumulative UV exposure.

Mechanism of Action

The efficacy of Melagm-EK lies in its synergistic "triple action" pathway:

Hydroquinone acts as a substrate for tyrosinase, competing with tyrosine. This prevents the formation of new melanin in the melanocytes. Over time, the existing pigment fades as the skin naturally exfoliates.

Tretinoin speeds up the mitotic rate of epidermal cells. By forcing the skin to produce new, non-pigmented cells faster, it helps "push out" the dark pigment residing in the upper layers of the skin. It also prevents the clogging of pores, which is beneficial for patients with concurrent acne.

Hydroquinone and Tretinoin can be inherently irritating to the skin barrier. The corticosteroid component (such as Mometasone) reduces redness, swelling, and itching, making the treatment tolerable for long-term daily use during the prescribed window.

Application Protocol

To achieve optimal results and minimize the risk of side effects, the following protocol is recommended:

Timing: Apply strictly at night, approximately 30 minutes before bedtime.

Preparation: Cleanse the face with a mild, soap-free cleanser and pat dry. Wait 10 minutes to ensure the skin is completely dry before application to reduce irritation.

Quantity: Use a pea-sized amount for the entire face or a thin film only on the affected areas.

Sun Protection: Daytime use of a broad-spectrum SPF 30+ sunscreen is mandatory. The ingredients in Melagm-EK make the skin highly photosensitive; failure to protect the skin from UV rays can lead to "rebound hyperpigmentation."

Safety and Contraindications

Melagm-EK is a potent medical-grade cream and should not be used as a general cosmetic moisturizer.

Contraindications

Pregnancy and Nursing: Tretinoin is a retinoid and is contraindicated due to potential teratogenic risks.

Hypersensitivity: Known allergy to sulfites (often used as stabilizers in hydroquinone) or any other component.

Broken Skin: Should not be applied to eczematous, sunburnt, or abraded skin.

Common Side Effects

Mild stinging or burning upon application.

Erythema (redness) and desquamation (peeling).

Temporary skin dryness.

Rare but Serious Risks

Ochronosis: A bluish-black darkening of the skin caused by long-term, unsupervised use of high-concentration hydroquinone.

Skin Atrophy: Thinning of the skin caused by the prolonged use of corticosteroids.

Patient Advice and Storage

Storage: Keep the tube tightly closed and store in a cool, dark place (below 25°C). Hydroquinone oxidizes when exposed to air and light, turning brown and losing potency.

Patience: Results are typically visible after 2 to 4 weeks of consistent use. Maximum results are seen at 8 weeks.

Discontinuation: Do not use continuously for more than 3-4 months without a "holiday" period to prevent the risk of ochronosis.